-
D. Boral Capital Reaffirms Buy Rating for Context Therapeutics (NASDAQ:CNTX)
来源: Buzz FX / 15 1月 2025 06:41:15 America/Chicago
D. Boral Capital Reaffirms Buy Rating for Context Therapeutics (NASDAQ:CNTX) Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Context Therapeutics ( NASDAQ:CNTX - Get Free Report ) 's stock had its "buy" rating reaffir
Read more...